Two Sigma Investments’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.55M Sell
238,888
-106,919
-31% -$3.38M 0.01% 961
2025
Q1
$11.5M Buy
345,807
+70,213
+25% +$2.33M 0.02% 686
2024
Q4
$9.48M Buy
275,594
+132,595
+93% +$4.56M 0.02% 734
2024
Q3
$5.72M Buy
142,999
+49,640
+53% +$1.99M 0.01% 975
2024
Q2
$2.82M Buy
93,359
+22,876
+32% +$690K 0.01% 1264
2024
Q1
$2.37M Buy
70,483
+60,479
+605% +$2.03M 0.01% 1306
2023
Q4
$323K Sell
10,004
-114,837
-92% -$3.71M ﹤0.01% 2583
2023
Q3
$4.09M Sell
124,841
-233,252
-65% -$7.64M 0.01% 947
2023
Q2
$12.6M Buy
358,093
+129,170
+56% +$4.55M 0.03% 513
2023
Q1
$7.47M Buy
228,923
+45,577
+25% +$1.49M 0.02% 679
2022
Q4
$10.1M Buy
183,346
+46,509
+34% +$2.56M 0.03% 526
2022
Q3
$6.06M Buy
136,837
+101,837
+291% +$4.51M 0.02% 659
2022
Q2
$1.71M Sell
35,000
-193,000
-85% -$9.41M 0.01% 1228
2022
Q1
$11.1M Buy
228,000
+216,491
+1,881% +$10.5M 0.03% 562
2021
Q4
$491K Buy
+11,509
New +$491K ﹤0.01% 1993
2021
Q1
Sell
-7,888
Closed -$285K 2483
2020
Q4
$285K Buy
+7,888
New +$285K ﹤0.01% 1745